Influenza and pneumococcal vaccination of the elderly in Taiwan

Vaccine

Volumn 22, Issue 21-22, 2004, Pages 2806-2811

  Chen, Yeong Hwang ^a   Liou, Saou Hsing ^b   Chou, Chih Chieh ^a   Su, Wen Lin ^a   Loh, Ching Hui ^a   Lin, Shih Ha ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Adverse reaction; Influenza vaccine; Pneumococcal vaccine

Indexed keywords

INFLUENZA VACCINE;

AGED; ARTHRALGIA; ARTICLE; ASTHMA; CAUSE OF DEATH; CHILL; CHRONIC BRONCHITIS; DRUG EFFECT; DRUG FEVER; ECCHYMOSIS; EDEMA; FATIGUE; HEADACHE; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INJECTION PAIN; LUNG EMPHYSEMA; MAJOR CLINICAL STUDY; MORTALITY; MYALGIA; PNEUMONIA; PRIORITY JOURNAL; SCAR; SIDE EFFECT; STREPTOCOCCUS INFECTION; SWEATING; TAIWAN; VERTIGO;

ADULT; AGE FACTORS; AGED; ASTHMA; BRONCHITIS; DISEASE OUTBREAKS; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PNEUMONIA; PULMONARY EMPHYSEMA; RISK FACTORS; TAIWAN;

EID: 3142649070     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.01.003     Document Type: Article

References (27)

1. CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization (ACIP). MMWR 2001;50(RR-4):1-45.
2. CDC. Influenza. In: Atkinson W, et al., editors. Influenza in epidemiology and prevention of vaccine-preventable diseases. 7th ed. Washington, DC: Department of Health and Human Services, Public Health Service; 2003. p. 190-204.
3. CDC. Influenza activity - United States, 1999-2000 season. MMWR 1999;48:1039-42.
4. WHO. Recommended composition of influenza virus vaccines for use in the 2001-2002 season. Wkly. Epidemiol. Rec. 2001;76:58-61.
5. CDC. Influenza A - Florida and Tennessee, July-August 1998, and virologic surveillance of influenza, May-August. MMWR 1998;47:756-9.
6. CDC. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization (ACIP), MMWR 1997;46(RR-8):1-24.
7. CDC. Pneumococcal disease. In: Atkinson W et al., editors. Epidemiology and prevention of vaccine-preventable diseases. 7th ed. Washington, DC: Department of Health and Human Services, Public Health Service; 2003. p. 205-17.
8. Appelbaum P.C. Epidemiology and in vitro susceptibility of drug-resistant Streptococcus pneumoniae. Ped Inf Dis J. 15(10):1995;932-939
9. Gross P.A., Hermogenes A.W., Sacks H.S., Lau J., Levandowski R.A. Efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the literature. Ann Intern Med. 123:1995;518-527
10. Tseng R.K., Chen H.Y., Horng C.B. Influenza virus infections in Taiwan from 1979-1999. J. Formos Med Assoc. 94:1995;S126-36
11. Tsai H.P., Kuo P.H., Liu C.C., Wang J.R. Respiratory viral infections among pediatric inpatients and outpatents in Taiwan from 1997 to 1999. J. Clin Microbiol. 39:2001;111-118
12. Cox N.J., Subbarao K. Influenza. Lancet. 354:1999;1277-1282
13. White T., Lavoie S., Nettleman M.D. Potential cost savings attributable to influenza vaccination of school-aged children. Pediatrics. 106:2000;973-976
14. CDC. Implementation of the Medicare influenza vaccination benefit - United States, 1993. MMWR 1994;43:771-3.
15. Christenson B., Lundbergh P., Hedlung J., Ortqvist A. Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study. Lancet. 357:2001;1008-1011
16. Voordouw B.C., van der Linden P.D., Simonian S., van der Lei J., Sturkenboom M.C., Stricker B.H. Influenza vaccination in community-dwelling elderly: impact on mortality and influenza-associated morbidity. Arch Intern Med. 163:2003;1089-1094
17. Nichol K.L., Wuorenma J., von Sternberg T. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Arch Intern Med. 158:1998;1769-1776
18. Nordin J., Mullooly J., Poblete S., Strikas R., Petrucci R., Wei F., et al. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. J. Infect Dis. 184:2001;665-670
19. Fedson D.S., Wajda A., Nicol J.P., Hammond G.W., Kaiser D.L., Roos L.L. Clinical effectiveness of influenza vaccination in Manitoba. JAMA. 270:1993;1956-1961.. [Erratum, JAMA 1994;271:1578].
20. Puig-Barbera J., Marquez-Calderon S., Masoliver-Fores A., Lloria-Paes F., Ortega-Dicha A., Gil-Martin M., et al. Reduction in hospital admissions for pneumonia in non-institutionalised elderly people as a result of influenza vaccination: a case-control study in Spain. J. Epidemiol Community Health. 51:1997;526-530
21. Crocetti E., Arniani S., Bordoni F., Maciocco G., Zappa M., Buiatti E. Effectiveness of influenza vaccination in the elderly in a community in Italy. Eur J. Epidemiol. 17:2001;163-168
22. Vu T., Farish S., Jenkins M., Kelly H. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine. 20:2002;1831-1836
23. Barker W.H., Mullooly J.P. Influenza vaccination of elderly persons. Reduction in pneumonia and influenza hospitalizations and deaths. JAMA. 244:1980;2547-2549
24. Ahmed A.E., Nicholson K.G., Nguyen-Van-Tam J.S. Reduction in mortality associated with influenza vaccine during 1989-90 epidemic. Lancet. 346:1995;591-595
25. Hak E., Nordin J., Wei F., Mullooly J., Poblete S., Strikas R., et al. Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations. Clin Infect Dis. 35:2002;370-377
26. Nichol K.L. The additive benefits of influenza and pneumococcal vaccinations during influenza seasons among elderly persons with chronic lung disease. Vaccine. 17(Suppl 1):1999;S91-3
27. Nichol K.L., Nordin J., Mullooly J., Lask R., Fillbrandt K., Iwane M. Influenza vaccine and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Eng J. Med. 348:2003;1322-1332